Renaissance Capital logo

QLGN News

Ritter Pharmaceuticals prices IPO at downwardly revised price of $5; now has $39 million market cap

Ritter Pharmaceuticals, which is developing an oral therapy that reduces the symptoms of lactose intolerance, raised $20 million by offering 4.0 million shares at $5.00. The health care company had been scheduled to price last week, but pushed back the...read more

Week ahead: As many as 17 IPOs could price during the week of June 22

TRU

17 companies are on the calendar to go public this week and raise $2.5 billion. It should be the year's most active week in the IPO market; the second busiest week saw 10 IPOs in...read more

Ritter Pharmaceuticals drops proposed IPO price; market cap down 45% to $39 million

Ritter Pharmaceuticals, which is developing an oral therapy that reduces the symptoms of lactose intolerance, lowered the proposed offer price for its upcoming IPO on Friday. The Los Angeles, CA-based company now plans to raise $20 million by offering 4...read more

Week ahead: Fitbit and 10 more IPOs planned for the week of June 15

FIT

Fitbit leads this week's 11 companies looking to raise over $1.7 billion through US initial public offerings. A good FIT Fitbit (FIT) flexes its muscle with the...read more